PMID- 19778329 OWN - NLM STAT- MEDLINE DCOM- 20100818 LR - 20131121 IS - 1600-0765 (Electronic) IS - 0022-3484 (Linking) VI - 45 IP - 1 DP - 2010 Feb TI - Matrix metalloproteinase-3 gene polymorphism in renal transplant patients with gingival overgrowth. PG - 143-7 LID - 10.1111/j.1600-0765.2009.01221.x [doi] AB - BACKGROUND AND OBJECTIVE: Gingival enlargement frequently occurs in transplant patients receiving immunosuppressive drugs. It was hypothesized that gingival enlargement associated with cyclosporine use results from reduced degradation of extracellular matrix in the gingiva. Matrix metalloproteinase-3 (MMP-3) is involved in biodegradation of the extracellular matrix, and its inhibition may contribute to an abnormal accumulation of fibronectin and proteoglycans, which are MMP-3 substrates. The aim of this study was to investigate whether an association exists between MMP-3 genotypes and gingival enlargement in kidney transplant patients medicated with cyclosporine A. MATERIAL AND METHODS: Sixty-four unrelated kidney transplant patients suffering from gingival overgrowth, as well as 111 control transplant patients without gingival overgrowth, were enrolled in the study. Gingival overgrowth was assessed 6 mo after transplantation. During the post-transplant period all patients were given cyclosporine A as a principal immunosuppressive agent. MMP-3 polymorphism was determined using a PCR restriction fragment length polymorphism assay. RESULTS: In kidney transplant patients suffering from gingival overgrowth the mean gingival overgrowth score was 1.35 +/- 0.57, whereas in control subjects the mean gingival overgrowth score was 0.0. The distribution of MMP-3-1178A/dupA alleles among all kidney transplant patients, as well as in the two study subgroups, did not differ significantly from Hardy-Weinberg equilibrium. The frequency of the MMP-3-1171A/A genotype (28.1% for gingival overgrowth vs. 26.1% for controls) and of the MMP-3-1171dupA/dupA genotype (32.8% for gingival overgrowth vs. 22.5% for controls) was similar for both study groups. The risk of gingival overgrowth was lowest among patients carrying the MMP-3-1171A/dupA genotype (odds ratio 0.52), but this did not differ markedly from the other genotypes. CONCLUSION: No association between MMP-3 gene polymorphism and gingival overgrowth was revealed in kidney transplant patients administered cyclosporine A. FAU - Drozdzik, A AU - Drozdzik A AD - Department of Periodontology, Pomeranian Medical University, Szczecin, Poland. drozdzik@sci.pam.szczecin.pl FAU - Kurzawski, M AU - Kurzawski M FAU - Lener, A AU - Lener A FAU - Kozak, M AU - Kozak M FAU - Banach, J AU - Banach J FAU - Drozdzik, M AU - Drozdzik M LA - eng PT - Journal Article DEP - 20090923 PL - United States TA - J Periodontal Res JT - Journal of periodontal research JID - 0055107 RN - 0 (Immunosuppressive Agents) RN - 83HN0GTJ6D (Cyclosporine) RN - EC 3.4.24.17 (MMP3 protein, human) RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) RN - JAC85A2161 (Adenine) SB - IM MH - Adenine MH - Adult MH - Aged MH - Alleles MH - Cyclosporine/adverse effects MH - Female MH - Follow-Up Studies MH - Gene Frequency MH - Genotype MH - Gingival Overgrowth/enzymology/*etiology MH - Humans MH - Immunosuppressive Agents/adverse effects MH - *Kidney Transplantation MH - Male MH - Matrix Metalloproteinase 3/*genetics MH - Middle Aged MH - Polymerase Chain Reaction MH - Polymorphism, Genetic/*genetics MH - Polymorphism, Restriction Fragment Length MH - Promoter Regions, Genetic/genetics MH - Young Adult EDAT- 2009/09/26 06:00 MHDA- 2010/08/19 06:00 CRDT- 2009/09/26 06:00 PHST- 2009/09/26 06:00 [entrez] PHST- 2009/09/26 06:00 [pubmed] PHST- 2010/08/19 06:00 [medline] AID - JRE1221 [pii] AID - 10.1111/j.1600-0765.2009.01221.x [doi] PST - ppublish SO - J Periodontal Res. 2010 Feb;45(1):143-7. doi: 10.1111/j.1600-0765.2009.01221.x. Epub 2009 Sep 23.